Evans SJ, Waller PC, Davis S
Pharmacies that rely on external stability data or general USP guidelines tend toward shorter BUDs, often 14 to 28 days
GLP-1 medications have multiple different mechanisms in the body that help with diabetes and weight loss, including: Increasing the amount of insulin made by the pancreas , which helps control blood sugar in patients with diabetes Decreasing the amount of excess sugar made by the pancreas , which helps control blood sugar in patients with diabetes Slowing down digestion from the stomach , which results in feeling full for longer after eating Signaling to your brain that you are full after eating , which helps suppress appetite and control cravings Tirzepatide contains an extra mechanism of action that other GLP-1 medications do not, known as GIP (glucose-dependent insulinotropic polypeptide) agonism
This article will break down the safety profiles, side effects, and clinical data of both medications to help you understand how they compare
Individual results vary based on dose, adherence, diet, and exercise habits, but most people experience meaningful weight reduction
